Home » Stocks » DXCM

DexCom, Inc. (DXCM)

Stock Price: $354.20 USD 2.12 (0.60%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $354.00 -0.20 (-0.06%) Jan 15, 7:54 PM
Market Cap 34.01B
Revenue (ttm) 1.82B
Net Income (ttm) 231.10M
Shares Out 95.80M
EPS (ttm) 2.42
PE Ratio 146.42
Forward PE 117.65
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $354.20
Previous Close $352.08
Change ($) 2.12
Change (%) 0.60%
Day's Open 352.23
Day's Range 347.59 - 356.75
Day's Volume 752,952
52-Week Range 191.16 - 451.79

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
The Motley Fool - 16 hours ago

The stock market's benchmark index is packed with big-time value.

Other stocks mentioned: AVGO, FB, MA
Zacks Investment Research - 2 days ago

DexCom (DXCM) posts solid fourth-quarter and full-year 2020 revenue data on the back of resilience shown in the face of the COVID-19 induced challenges.

Zacks Investment Research - 3 days ago

Teladoc (TDOC) and Dexcom jointly provide solutions for patients with Type 2 diabetes, a common lifestyle-induced malady.

Other stocks mentioned: TDOC
The Motley Fool - 3 days ago

These two providers of diabetes-related products and services have yet to scratch the surface of their potential.

Other stocks mentioned: TNDM
Business Wire - 4 days ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook

Zacks Investment Research - 1 week ago

DexCom (DXCM) closed the most recent trading day at $388.09, moving +0.24% from the previous trading session.

Business Wire - 1 week ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom to Present at 39th Annual J.P. Morgan Healthcare Conference

The Motley Fool - 1 week ago

These stocks can handle whatever the new year has in store.

Other stocks mentioned: REGN, VRTX
The Motley Fool - 1 week ago

The highflying Nasdaq 100 is hiding some serious value in plain sight.

Other stocks mentioned: FB, VRTX
The Motley Fool - 2 weeks ago

Businesses in these fast-growing trends can shine in a young bull market.

Other stocks mentioned: AMZN, GOOG, GOOGL, CRLBF, FRPT, GTBIF, TDOC, TRUP
Zacks Investment Research - 3 weeks ago

In the latest trading session, DexCom (DXCM) closed at $355.02, marking a -0.27% move from the previous day.

Seeking Alpha - 3 weeks ago

DexCom is an attractive company riding a long-term secular trend in the growth of chronic care management. Stock has performed well this year and is trading at the high range of historical ave...

Zacks Investment Research - 4 weeks ago

DexCom (DXCM) closed at $358.57 in the latest trading session, marking a +0.18% move from the prior day.

The Motley Fool - 4 weeks ago

This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love.

CNBC Television - 1 month ago

DexCom CEO: We're more bullish about the business than we've ever been

DexCom CEO Kevin Sayer reaffirms his long-term outlook for the diabetes management company, forecasting growth as high as 20% through 2025.

The Motley Fool - 1 month ago

Investors have a few questions as the company faces increasing competition.

The Motley Fool - 1 month ago

These companies have growth opportunities that will last long after the COVID vaccine gets life back to normal.

Other stocks mentioned: BNTX, QDEL
The Motley Fool - 1 month ago

These stocks could make you a fortune over the next decade.

Other stocks mentioned: DOCU, SHOP
Zacks Investment Research - 1 month ago

Medical device which has for long taken tiny steps toward IoMT is now going all out to make the most of the advancements in this space amid the pandemic.

Other stocks mentioned: PRAH, TDOC
The Motley Fool - 1 month ago

Probably not, but it'll still beat the market.

The Motley Fool - 1 month ago

Biotech stocks simply can't match these reliable returns.

Other stocks mentioned: MDT, ABMD
The Motley Fool - 1 month ago

These two companies are battling for market share of continuous glucose monitoring devices for diabetes, with each coming out with new models soon.

Other stocks mentioned: ABT
Seeking Alpha - 2 months ago

G7 could change the valuation dramatically. It is a risky play, especially in the short term.

The Motley Fool - 2 months ago

Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.

Other stocks mentioned: EXAS
Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Upcoming Virtual Conference Presentations

The Motley Fool - 2 months ago

These stocks have beaten the odds in 2020 and can weather future storms.

Other stocks mentioned: BDX, TDOC, UNH, VRTX
InvestorPlace - 2 months ago

With the disruption that the coronavirus caused us, the dependency on tech-based solutions makes these IoT stocks very relevant. The post 7 IoT Stocks That Are Banking on a Connected Future ap...

Other stocks mentioned: ALRM, CSCO, IBM, INTC, NVDA, NXPI
The Motley Fool - 2 months ago

An analyst downgrade and marketwide turbulence weighed on the medical device maker's shares last month.

The Motley Fool - 2 months ago

This medical device manufacturer has shown incredible momentum.

Investors Business Daily - 2 months ago

A Relative Strength Rating upgrade for Dexcom shows improving technical performance. The post Stock Upgrades: Dexcom Shows Rising Relative Strength appeared first on Investor's Business Daily.

InvestorPlace - 2 months ago

IOT stocks represent companies on the cusp of a new paradigm where everyday objects connect to the internet. Here are seven that stand out.

Other stocks mentioned: AMZN, CSCO, GOOG, GOOGL, HON, JCI
InvestorPlace - 2 months ago

If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?

Other stocks mentioned: GILD, IBB, IDXX, MRNA, PFE, QDEL
Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom to Host Investor Day on December 9, 2020

Zacks Investment Research - 2 months ago

DexCom's (DXCM) third-quarter results benefit from solid segmental performance.

The Motley Fool - 2 months ago

The diabetes care technology provider also again raised its full-year guidance.

Seeking Alpha - 2 months ago

DexCom, Inc. (DXCM) CEO Kevin Sayer on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

DexCom (DXCM) delivered earnings and revenue surprises of 46.88% and 4.96%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 months ago

Shares of DexCom (NASDAQ:DXCM) rose 1.15% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 44.62% over the past year to $0.94, which ...

Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Third Quarter 2020 Financial Results

Business Wire - 2 months ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue

The Motley Fool - 2 months ago

These fast-growing medical device companies could outperform the S&P 500 over the next several years.

Other stocks mentioned: NARI
Zacks Investment Research - 2 months ago

DexCom (DXCM) closed at $387.84 in the latest trading session, marking a -1.17% move from the prior day.

Zacks Investment Research - 2 months ago

DexCom's (DXCM) third-quarter results are likely to reflect rising global awareness of its real-time CGM.

Zacks Investment Research - 2 months ago

DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 2 months ago

DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Motley Fool - 2 months ago

These two healthcare companies have much more room to grow than the tech giant does.

Other stocks mentioned: TDOC
Business Wire - 3 months ago

SAN DIEGO--(BUSINESS WIRE)--Dexcom Appoints Kyle Malady to Board of Directors

Zacks Investment Research - 3 months ago

In the latest trading session, DexCom (DXCM) closed at $387.50, marking a -1.6% move from the previous day.

PRNewsWire - 3 months ago

INDIANAPOLIS and SAN DIEGO, Oct. 7, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and DexCom, Inc. (NASDAQ: DXCM) announced today a joint program for U.S. healthcare providers (HCPs) ...

Other stocks mentioned: LLY
The Motley Fool - 3 months ago

An analyst's downgrade is weighing on the medical device stock.

About DXCM

DexCom, a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring sys... [Read more...]

Industry
Diagnostics & Research
IPO Date
Apr 14, 2005
CEO
Kevin Sayer
Employees
3,900
Stock Exchange
NASDAQ
Ticker Symbol
DXCM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for DexCom stock is "Buy." The 12-month stock price forecast is 460.22, which is an increase of 29.93% from the latest price.

Price Target
$460.22
(29.93% upside)
Analyst Consensus: Buy